Benjamin Ebert, President and CEO of Dana-Farber Cancer Institute, shared a post by Dana-Farber Cancer Institute on LinkedIn, adding:
“AI holds tremendous potential to help accelerate cancer research.
Dana-Farber along with our partners at the Cancer AI Alliance are excited to launch the first scalable, federated learning platform for cancer research that will greatly increase access to data across the cancer research community and drive new discoveries that will benefit patients everywhere.”
Quoting Dana-Farber Cancer Institute‘s post:
“We’re proud to join Fred Hutch, Memorial Sloan Kettering Cancer Center, and Sidney Kimmel Comprehensive Cancer Center along with leading technology partners to launch the first collaborative AI platform for cancer research. The platform serves as the technological foundation of Cancer AI Alliance (CAIA)’s aim to save more lives by enabling researchers and clinicians to train AI models that learn from participating cancer centers’ millions of clinical data points while maintaining data security, privacy and adherence to regulatory and ethical standards.
The platform’s true power, however, lies in its potential to scale up. Over the next year, CAIA plans to enable dozens of research models and add more cancer centers and technology collaborators to the alliance.
You Can Also Read: Dana-Farber CEO Cycles to Support Life-Saving Mission
